PASSERI DANIEL R 4
4 · Cue Biopharma, Inc. · Filed Mar 29, 2022
Insider Transaction Report
Form 4
PASSERI DANIEL R
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Stock Option (right to buy)
2022-03-25+100,000→ 100,000 totalExercise: $5.01Exp: 2032-03-24→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]1. This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 25, 2022.